Kotak Healthcare Fund - Direct Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 14.251 ↑ 0.62%
[as on 20 October, 2025]

NAV chart with SMA (Simple moving average) overlay

SMA (Simple Moving Average)

  • 100 SMA
  • 200 SMA
  • 300 SMA
  • 400 SMA
  • 500 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Kotak Healthcare Fund - Direct Plan - Growth Option -2.48% 0.62% 1.57% 0.41% 1.06% 1.99%----

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
97.68% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 2.32%

Equity

NameSectorWeight %
SUN PHARMACEUTICAL INDUSTRIES LTD.Pharmaceuticals and Biotechnology13.05%
Max Healthcare Institute Ltd.Healthcare Services7.33%
JB Chemicals & Pharmaceuticals Ltd.Pharmaceuticals and Biotechnology5.93%
Cipla Ltd.Pharmaceuticals and Biotechnology5.51%
Divis Laboratories Ltd.Pharmaceuticals and Biotechnology4.90%
Apollo Hospitals Enterprise Ltd.Healthcare Services4.23%
Fortis Healthcare India LtdHealthcare Services4.18%
Lupin Ltd.Pharmaceuticals and Biotechnology3.91%
JUBILANT PHARMOVA LIMITEDPharmaceuticals and Biotechnology3.26%
KRISHNA INSTITUTE OF MEDICALHealthcare Services3.02%
Gland Pharma LimitedPharmaceuticals and Biotechnology3.00%
ASTER DM HEALTHCARE LTDHealthcare Services2.90%
ANTHEM BIOSCIENCES LTDPharmaceuticals and Biotechnology2.79%
Dr.Reddy's Laboratories Ltd.Pharmaceuticals and Biotechnology2.64%
MANKIND PHARMA LTDPharmaceuticals and Biotechnology2.62%
Alkem Laboratories Ltd.Pharmaceuticals and Biotechnology2.57%
Ami Organics LtdPharmaceuticals and Biotechnology2.56%
Glenmark Pharmaceuticals LtdPharmaceuticals and Biotechnology2.40%
Aurobindo Pharma Ltd.Pharmaceuticals and Biotechnology2.36%
Ajanta Pharma Ltd.Pharmaceuticals and Biotechnology2.33%
SAI LIFE SCIENCES LIMITEDPharmaceuticals and Biotechnology2.23%
LAXMI DENTAL LIMITEDHealthcare Equipment and Supplies2.10%
Marksans Pharma LtdPharmaceuticals and Biotechnology1.78%
INNOVA CAPTABS LTDPharmaceuticals and Biotechnology1.75%
Zydus Lifesciences Ltd.Pharmaceuticals and Biotechnology1.69%
Krsnaa Diagnostics LtdHealthcare Services1.63%
ORCHID PHARMA LIMITEDPharmaceuticals and Biotechnology1.51%
YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTDHealthcare Services1.44%
RAINBOW CHILDRENS MEDICARE LTDHealthcare Services1.36%
HIKAL LTDPharmaceuticals and Biotechnology0.70%
Portfolio data is as on date 30 September, 2025

NAV (Net asset value) history

Kotak Healthcare Fund - Direct Plan - Growth Option - 30 days NAV history

DateNAV
20 October, 202514.251
17 October, 202514.163
16 October, 202514.102
15 October, 202514.02
14 October, 202513.97
13 October, 202514.031
10 October, 202514.03
9 October, 202513.904
8 October, 202513.798
7 October, 202513.804
6 October, 202513.801
3 October, 202513.635
1 October, 202513.67
30 September, 202513.523
29 September, 202513.536
26 September, 202513.549
25 September, 202513.794
24 September, 202513.902
23 September, 202514.019
22 September, 202514.071
19 September, 202514.193
18 September, 202514.16
17 September, 202514.067
16 September, 202514.062
15 September, 202514.01
12 September, 202514.057
11 September, 202514.037
10 September, 202514.01
9 September, 202513.935
8 September, 202513.849

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Kotak Healthcare Fund - Direct Plan - Growth Option?
    The latest NAV of Kotak Healthcare Fund - Direct Plan - Growth Option is 14.251 as on 20 October, 2025.
  • What are YTD (year to date) returns of Kotak Healthcare Fund - Direct Plan - Growth Option?
    The YTD (year to date) returns of Kotak Healthcare Fund - Direct Plan - Growth Option are -2.48% as on 20 October, 2025.
  • What are 1 year returns of Kotak Healthcare Fund - Direct Plan - Growth Option?
    The 1 year returns of Kotak Healthcare Fund - Direct Plan - Growth Option are 1.99% as on 20 October, 2025.